Discover Tenders by Antiretroviral Drugs Sector

Find the most relevant tenders for Antiretroviral Drugs. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Antiretroviral Drugs tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Antiretroviral Drugs tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Methotrexate Pen Note Strength And Ng

Deadline: 10 Nov 2025

Germany

Ref. No.: 5803509

EMD:Ref Document

Bid Value: Ref Document

47 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Mebeverine

Deadline: 10 Nov 2025

Germany

Ref. No.: 5801461

EMD:Ref Document

Bid Value: Ref Document

47 Days Left

Drug Contracts With An Option To Join

Deadline: 01 May 2026

Germany

Ref. No.: 5779195

EMD:Ref Document

Bid Value: Ref Document

219 Days Left

Drug Contracts With An Option To Join

Deadline: 01 May 2026

Germany

Ref. No.: 5774951

EMD:Ref Document

Bid Value: Ref Document

219 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ranibizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5730369

EMD:Ref Document

Bid Value: Ref Document

228 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5728730

EMD:Ref Document

Bid Value: Ref Document

228 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Mebeverine A03Aa04 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5728537

EMD:Ref Document

Bid Value: Ref Document

218 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5727706

EMD:Ref Document

Bid Value: Ref Document

228 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Pomalidomide Atc Code L04Ax06

Deadline: 27 Apr 2026

Germany

Ref. No.: 5727505

EMD:Ref Document

Bid Value: Ref Document

215 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Aclidinium Bromide Atc Code According To Who R03Bb05

Deadline: 28 Feb 2026

Germany

Ref. No.: 5727483

EMD:Ref Document

Bid Value: Ref Document

157 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tacrolimus L04Ad02 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5726196

EMD:Ref Document

Bid Value: Ref Document

218 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Sirolimus L04Ah01 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5721216

EMD:Ref Document

Bid Value: Ref Document

218 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5720077

EMD:Ref Document

Bid Value: Ref Document

228 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Rituximab

Deadline: 11 May 2026

Germany

Ref. No.: 5719969

EMD:Ref Document

Bid Value: Ref Document

229 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

Deadline: 11 May 2026

Germany

Ref. No.: 5719627

EMD:Ref Document

Bid Value: Ref Document

229 Days Left

Showing 43021 to 43035 of 43166 results

‹
1
2
...
2866
2867
2868
2869
2870
2871
2872
...
2877
2878
›

Discover Tenders by Antiretroviral Drugs Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Antiretroviral Drugs Sector

Filter Your Search

FREE Trial plan for all new users!